Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery...

Area of Science:

• Regenerative Medicine
• Nephrology
• Vascular Biology

Background:

• Renovascular disease impairs kidney function.
• Endothelial progenitor cells (EPC) and mesenchymal stem cells (MSC) show promise in tissue repair.
• Understanding cell-specific mechanisms in renovascular disease is crucial.

Purpose of the Study:

• To test if EPCs and MSCs protect kidneys in renovascular disease via distinct pathways.
• To compare the efficacy of EPCs and MSCs in improving kidney hemodynamics and function post-stenosis.

Main Methods:

• Characterization of peripheral blood EPCs and adipose-derived MSCs.
• Assessment of kidney hemodynamics and function in pigs with renal artery stenosis (RAS) treated with EPCs, MSCs, or vehicle.
• Ex vivo evaluation of kidney disease mechanisms and cellular stress pathways (ER stress, apoptosis).

Main Results:

• Both EPCs and MSCs improved renal blood flow similarly in RAS.
• MSCs significantly enhanced glomerular filtration rate compared to EPCs.
• EPCs increased renal growth factors and decreased oxidative stress.
• MSCs more effectively reduced renal inflammation, ER stress, and apoptosis, including caspase-3 and CHOP expression.

Conclusions:

• EPCs and MSCs mitigate kidney injury in renovascular disease through different mechanisms.
• MSCs demonstrated a slightly superior improvement in renal function.
• Cell selection should be guided by the specific pathophysiology of kidney injury in renovascular disease.